Help us make childhood cancer universally survivable.
By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.
Our team is on a mission to make childhood cancer universally survivable!
The FDA approves on average 12 drugs every year to treat adult cancer, but has only approved 10 drugs to treat childhood cancer since 1978 (10 in 44 years for kids).
Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.
giving back childhood for Sophie Shane Thomas Alexa Cooper Joseph Addie Finn Bode Hunter George Zack Samara
#GIVINGBACKCHILDHOOD
Latest News
Megan’s Mission Awards $222,120 in RMS Support
The Children’s Cancer Therapy Development Institute (cc-TDI) has been awarded $222,120 by the Megan’s Mission Foundation to advance three clinical research initiatives focused on Rhabdomyosarcoma (RMS). This 2024 funding expands support for the Immunotherapy Project for use in RMS, furthering the Citizen Scientist Project “Key Knowledge” Initiative looking at PAX3::FOXO1 protein degrader therapies, and the hiring of Alina Teuber, PhD, cc-TDI’s first Megan Bugg Research Fellow. Since 2020, Megan Bugg and her supporters through Team Megan Bugg, now the Megan’s Mission Foundation, have raised more than $2,000,000 for childhood cancer research. This funding has driven
Our Why: Conquering Rare Childhood Cancers for Michele
Sharing our Why: Science-Justified Hope
Entinostat as a combinatorial therapeutic for RMS
Claire Newman appointed new Executive Director
In the Press
Current Research Projects
A dedicated research team
Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer.
Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.